Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p72 | Bone development/growth and fracture repair | ECTS2016

Sulfated hyaluronan improves bone defect healing in type 2 diabetic rats by increasing osteoblast function

Picke Ann-Kristin , Salbach-Hirsch Juliane , Hintze Vera , Rauner Martina , Moller Stephanie , Kascholke Christian , Hacker Michael C , Schulz-Siegmund Michaela , Schnabelrauch Matthias , Scharnweber Dieter , Hofbauer Lorenz C , Hofbauer Christine

Bone fractures of patients suffering from type 2 diabetes mellitus (T2DM) represent an emerging socioeconomic problem. Underling mechanisms are poorly understood and therapies are limited. Our previous studies have shown that sulfated hyaluronan (sHA3) suppresses osteoclast activity while supporting osteoblast function in vitro. Hence, we now investigated if sHA3 can improve the delayed fracture healing in rats with T2DM.Porous, cross-linked lactide-base...

ba0001pp123 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Vitamin D supplementation during lactation: effect on maternal and offspring's vitamin D status and bone mass–double-blind randomized control trial

Czech-Kowalska Justyna , Jaworski Maciej , Latka-Grot Julita , Bulsiewicz Dorota , Pludowski Pawel , Chazan Bogdan , Pawlus Beata , Wygledowska Grazyna , Zochowska Anna , Kornacka Maria K , Kryskiewicz Edyta , Karczmarewicz Elzbieta , Dobrzanska Anna

Introduction: Optimal vitamin D intake for lactating women remains controversial. We hypothesized that 1200 IU/day (vs 400 IU/day) of vitamin D during breastfeeding will enhance maternal vitamin D status and bone mass.Methods: Healthy mothers after term, singleton delivery were randomized to receive vitamin D3: 1200 IU/day (800+400 IU/day from multivitamins) or 400 IU/day (placebo+400 IU/day from multivitamins) during lactation. Serum 25-hydroxyvitamin D...

ba0001pp278 | Genetics | ECTS2013

Gene-wide association study of RANK and RANKL genes in the bone context: functional study of BMD-associated SNPs

Garcia-Giralt Natalia , Yoskovitz Guy , Rodriguez-Sanz Maria , Urreizti Roser , Guerri Roberto , Arino-Ballester Sergi , Prieto-Alhambra Daniel , Mellibovsky Leonardo , Grinberg Daniel , Nogues Xavier , Balcells Susana , Diez-Perez Adolfo

Over the past decade, many GWAs and meta-analyses were performed to identify genes and regions involved in bone metabolism and in the osteoporotic phenotypes. Nevertheless, the majority of these GWAS results were not tested at any functional level. This study aims to find and study functional regions in the RANK and RANKL genes that encode well-established proteins in the bone remodeling equilibrium. SNPs, chosen for their location in an evolutionary conserve...

ba0003pp213 | Osteoporosis: evaluation and imaging | ECTS2014

HIV patients have deteriorated bone material properties assessed by in vivo microindentation

Guerri-Fernandez Robert , Villar-Garcia Judit , Molina-Morant Daniel , Torres-del-Pliego Elisa , Garcia-Giralt Natalia , Vilaplana-Marz Laia , Rodriguez Maria , Mena Alicia Gonzalez , Knobel Hernando , Nogues Xavier , Mellibovsky Lenoardo , Horcajada Juan Pablo , Diez-Perez Adolfo

There is a growing evidence of the association between HIV infection and fracture risk. Independently of its cause (antiretroviral therapy (ART) or HIV), what remains most important is a prompt diagnosis. Although densitometry is the gold standard, sometimes this technique is not as accurate as necessary in clinical practice. A new validated tool for early and more accurate diagnosis is presented.MethodsIn a HIV group of patients, ...

ba0005oc4.6 | Catabolism and metabolism | ECTS2016

The myokine Irisin improves bone quality and strength

Colaianni Graziana , Cuscito Concetta , Mongelli Teresa , Pignataro Paolo , Liu Peng , Lu Ping , Mori Giorgio , Brunetti Giacomina , Yuen Tony , Sun Li , Reseland Janne , Colucci Silvia , Zaidi Mone , Cinti Saverio , Grano Maria

Irisin is a hormone-like myokine secreted from skeletal muscle in response to exercise. Considering that an intimate relationship between skeletal muscle and bone has been well established and that physical exercise physiologically stimulates the skeleton strengthening, we explored the involvement of Irisin on bone metabolism.Our findings demonstrated that the myokine Irisin improves cortical bone mass and geometry in vivo, supporting the idea t...

ba0005p8 | Arthritis and other joint diseases: translational and clinical | ECTS2016

A clinical study to examine thresholds of joint space width and joint space area for identification of knee osteoarthritis

Ljuhar Richard , Norman Benjamin , Ljuhar Davul , Haftner Tobias , Hladuvka Jiri , Mai Mary Bui Thi , Canhao Helena , Rodrigues Ana Maria , Gouveia Nelia , Branco Jaime , Nehrer Stefan , Fahrleitner-Pammer Astrid , Dimai Hans-Peter

Objective: Osteoarthritis (OA) is a degenerative, slowly developing joint disease. Although clinical indications of OA can vary among different definitions there is a general agreement that the disease is associated with cartilage narrowing. However, there is no general consensus about the threshold below which the joint space width (JSW)/joint space area (JSA) can be certain indicators for the state of OA. Therefore this study evaluates these limits to reveal quantitative inf...

ba0005p128 | Cancer and bone: basic, translational and clinical | ECTS2016

The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)ethyl-bisphosphonate), with reduced bone affinity, which is as effective as zoledronate in the treatment of myeloma bone disease in JJN3-NOD/SCID-γ mice

Lawson Michelle , Chantry Andrew , Paton-Hough Julia , Evans Holly , Lath Darren , Tsoumpra Maria , Lundy Mark , Dobson Roy , Quijano Michael , Kwaasi Aaron , Dunford James , Duan Xuchen , Triffit James , Mazur Adam , Jeans Gwyn , Russell Graham , Ebetino Hal

Bisphosphonates are used in the treatment of a variety of diseases with skeletal complications. With the development of more potent compounds, there is the potential for further improvement. One concept is to use compounds with a reduced affinity for bone, reducing their long-term retention and possible adverse events, as well as potentially enhancing their non-skeletal benefits. We hypothesise that a highly potent bisphosphonate with low bone affinity, known as OX14, will be ...

ba0005p203 | Cell biology: osteoclasts and bone resorption | ECTS2016

The role of light (TNFSF14) on bone remodeling

Brunetti Giacomina , Gigante Isabella , Oranger Angela , Colaianni Graziana , Di Benedetto Adriana , Tamma Roberto , Lippo Luciana , Pignataro Paolo , Di Comite Mariasevera , Mori Giorgio , Tamada Koji , Ware Carl , Colucci Silvia , Grano Maria

LIGHT (TNFSF14), expressed by different cells of the immune system, binds two trans-membrane receptors: HVEM and LTβR. It is over-expressed in erosive rheumatoid arthritis and lytic myeloma-bone disease and controversial data have been published on its role osteoclast (OC) formation in vitro. Here, we investigated the role of LIGHT on in vitro murine osteoclastogenesis model and bone phenotype in LIGHT−/− mice. Firstly, we showed that murin...

ba0005p367 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

FGF23 and SCL are expressed in carotid plaques and the association between their circulating fractions and fractures differs in relation to comorbidity in elderly individuals

Rotatori Stefano , Corallo Claudio , Merlotti Daniela , Rendina Domenico , Bianciardi Simone , Patti Aurora , Gonnelli Stefano , Evangelista Isabella Anna , Lucani Barbara , Franci Maria Beatrice , Setacci Carlo , Strazzullo Pasquale , Nuti Ranuccio , Dotta Francesco , Gennari Luigi

Sclerostin (SCL) and FGF23 are osteocyte-secreted factors with a major role in bone homeostasis. Despite their skeletal effects and their association with fracture risk in some studies, variations in circulating levels were also described in patients with diabetes (DM), chronic renal failure (CRF) and/or cardiovascular disease (CVD). In order to provide further insight on the relationship between these osteocyte-derived factors, osteoporosis and cardio-metabolic disorders we a...